THP1-Dual™ KO-MyD88 Cells
THP1-Dual KO-MyD Cells | Unit size | Cat. code | Docs | Qty | Price |
---|---|---|---|---|---|
Human THP-1 Monocytes - MyD88 knockout NF-kB-SEAP and IRF-Lucia Reporter |
3-7 x 10e6 cells |
thpd-komyd |
You may also need : THP1-Dual™ Cells | View more associated products ▼
MyD88 knockout dual reporter monocytes
THP1-Dual™ KO-MyD cells were specifically designed to monitor MyD88-mediated signaling.
They were generated from THP1-Dual™cells by stable knockout of the MyD88 gene. They stably express two inducible secreted reporter genes: Lucia luciferase and SEAP (secreted embryonic alkaline phosphatase).
The Lucia luciferase reporter gene is under the control of an ISG54 (interferon-stimulated gene) minimal promoter in conjunction with five IFN-stimulated response elements.
The SEAP gene is driven by an IFN-β minimal promoter fused to five copies of the NF-κB consensus transcriptional response element and three copies of the c-Rel binding site.
As a result, they allow the simultaneous study of the IFN regulatory factor (IRF) pathway, by assessing the activity of Lucia luciferase and the NF-κB pathway, by monitoring the activity of SEAP. Both reporter proteins are readily measurable in the cell culture supernatant when using QUANTI‑Luc™ 4 Lucia/Gaussia, a Lucia and Gaussia luciferase detection reagent, and QUANTI-Blue™ Solution, a SEAP detection reagent.
THP1-Dual™ KO‑MyD cells are unable to respond to the activation of receptors whose signaling is dependent on MyD88, such as TLR2, TLR4, TLR5, TLR8 and IL-1Rs.
These cells remain responsive to MyD88‑independent receptors, such as NOD1 and TNFR. Activation of the IRF pathway is unaffected by the knockout of the MyD88 gene.
THP1-Dual™ KO-MyD cells are resistant to the selectable markers blasticidin and Zeocin®.
Key features:
- Verified knockout of the hMyD88 gene
- Functionally validated on a selection of TLR4 and other PRR ligands and cytokines
- Distinct monitoring of NF-κB and IRF activation by assessing the SEAP and Lucia luciferase activities
Applications:
- Defining the role of MyD88 in PRR-induced signaling (e.g. TLR2, TLR4), or related cell signaling pathways
- Highlighting possible overlap between MyD88 and other signaling pathways
Specifications
Growth medium: RPMI 1640, 2 mM L-glutamine, 25 mM HEPES, 10% heat-inactivated fetal bovine serum, 100 μg/ml Normocin™, Pen-Strep (100 U/ml-100 μg/ml)
Antibiotic resistance: Blasticidin and Zeocin®
Quality control:
- Biallelic MyD88 knockout has been verified by PCR, DNA sequencing, Western blot, and functional assays.
- The stability for 20 passages, following thawing, has been verified.
- These cells are guaranteed mycoplasma-free.
This product is covered by a Limited Use License (See Terms and Conditions).
Back to the topContents
- 3-7 x 106 THP1-Dual™ KO-MyD cells in a cryovial or shipping flask
- 1 ml of Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasmas, bacteria and fungi.
- 1 ml of Zeocin® (100 mg/ml)
- 1 ml of Blasticidin (10 mg/ml)
- 1 tube of QUANTI-Luc™ 4 Reagent, a Lucia luciferase detection reagent (sufficient to prepare 25 ml)
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
Shipped on dry ice (Europe, USA, Canada, and some areas in Asia)
Description
THP1 reporter cells are a family of cells derived from the human monocytic THP-1 cell line, which naturally expresses many pathogen recognition receptors (PRRs), including Toll-like receptors.
They respond to ligands for certain TLRs; namely, TLR2, TLR1/2, TLR2/6, TLR4, TLR5 and TLR8. These cells can also be used to study DNA sensing pathways, as they are highly responsive to PRR agonists that trigger interferon (IFN) signaling pathways.
THP1‑Dual™ cells feature two reporter genes that enable the simultaneous study of the NF-κB and IFN signaling pathways.
Back to the top